Katsube, Takayuki http://orcid.org/0000-0001-9569-716X
Kezbor, Safwan
Shimizu, Ryosuke
Kubota, Ryuji
Funding for this research was provided by:
Shionogi
Article History
Received: 24 January 2024
Accepted: 20 February 2024
First Online: 9 March 2024
Declarations
:
: Takayuki Katsube, Ryosuke Shimizu, and Ryuji Kubota are employees of Shionogi & Co., Ltd. Kezbor Safwan is an employee of Shionogi Inc.
: This study (NCT05363215) was conducted in accordance with the protocol. The study protocol was approved by the Declaration of Helsinki and Council for International Organizations of Medical Sciences International Ethical Guidelines, the Institutional Review Board, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice Guidelines, and other regulations and applicable laws. The Institutional Review Board also approved the study. All participants in this study gave their written informed consent for participation [CitationRef removed–CitationRef removed].